Private Advisor Group’s Definium Therapeutics DFTX Stock Holding History

Private Advisor Group’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$627K	Buy	+13,336	New	+$330K	﹤0.01%	1634
2022 Q3	–	Sell	-2,404	Closed	-$23K	–	2051
2022 Q2	$23K	Buy	+2,404	New	+$30.4K	﹤0.01%	2068
2022 Q1	–	Sell	-1,714	Closed	-$36K	–	2206
2021 Q4	$36K	Sell	1,714 -2,320	-58%	-$74K	﹤0.01%	2092
2021 Q3	$140K	Buy	4,034 +1,288	+47%	+$55.7K	﹤0.01%	1920
2021 Q2	$141K	Buy	+2,746	New	+$144K	﹤0.01%	1873

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Private Advisor Group's DFTX Position: Q2 2026 in Review

Private Advisor Group opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 13,336 shares worth $627K. The stake represents ﹤0.01% of the portfolio and ranks #1634 among its holdings. This is a return to the name: Private Advisor Group previously reported a position in DFTX as recently as Q2 2022.

Private Advisor Group first reported a position in DFTX in Q2 2021 and has held it in 5 quarters since. 361 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Private Advisor Group held 13,336 shares of Definium Therapeutics worth $627K as of Q2 2026.
Definium Therapeutics was a new Private Advisor Group position in Q2 2026.
Definium Therapeutics made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #1634 holding.
Private Advisor Group first reported a position in Definium Therapeutics in Q2 2021 and has held it in 5 quarters since.
361 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.